CERo Therapeutics Holdings, Inc. is experiencing a significant drop in its stock price today, primarily due to the announcement of a reverse stock split on January 6, 2025. This move often signals financial distress or an attempt to meet exchange listing requirements, which can lead to negative investor sentiment. Additionally, the company's recent filing to sell common stock and warrants, although the amount was not specified, may have further contributed to the downward pressure on the stock as investors anticipate potential dilution.
The stock opened at $3.36 and has since fallen to $2.88, marking a 22.17% decrease from the previous close of $3.70. Despite being just half an hour into the trading day, the stock has already seen a volume of 232,733 shares, which is 24.47% of its average daily volume of 951,034 shares, indicating a notable level of trading activity early in the session.